Expected next investor conference call information:
Conference Call Date: 10/22/2009
Conference Call Time (ET): 8:00 AM
Conference Call URL: http://investor.zimmer.com/eventdetail.cfm?eventid=73727&id=15

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2008 sales were approximately $4.1 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

For more information about Zimmer, visit www.zimmer.com

SOURCE Zimmer Holdings, Inc.

http://www.zimmer.com

Copies of the prospectus may be obtained by calling or e-mailing Banc of America Securities LLC at 1-800-294-1322 or dg.prospectus_distribution@bofasecurities.com, by calling Citigroup Global Markets Inc. toll free at 1-877-858-5407, or by calling J.P. Morgan Securities Inc. at (212) 834-4533.

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2008 sales were approximately $4.1 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

This press release contains forward-looking statements regarding our intended use of proceeds and the anticipated closing of the notes offering, which are subject to risks and uncertainties, including the general economic conditions and other risks and uncertainties described in our Annual Report on Form 10-K for the year ended December 31, 2008 and subsequent quarterly reports. Actual results may differ materially from anticipated results. We do not undertake to update any forward-looking statements.

For more information about Zimmer, visit www.zimmer.com

SOURCE Zimmer Holdings, Inc.

http://www.zimmer.com

Banc of America Securities LLC, Citigroup Global Markets Inc. and J.P. Morgan Securities Inc. are serving as active joint book-running managers of the offering. Any offer of securities will be made by means of the prospectus. When available, copies of the prospectus may be obtained for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send the prospectus if it is requested by calling or e-mailing Banc of America Securities LLC at 1-800-294-1322 or dg.prospectus_distribution@bofasecurities.com, by calling Citigroup Global Markets Inc. toll free at 1-877-858-5407, or by calling J.P. Morgan Securities Inc. at (212) 834-4533.

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2008 sales were approximately $4.1 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

This press release contains forward-looking statements regarding our intended use of proceeds and anticipated use of our shelf registration statement, which are subject to risks and uncertainties, such as our ability to market and sell the notes, our continued eligibility to use the shelf registration statement, general economic conditions and other risks and uncertainties described in our Annual Report on Form 10-K for the year ended December 31, 2008 and subsequent quarterly reports. Actual results may differ materially from anticipated results. We do not undertake to update any forward-looking statements.

For more information about Zimmer, visit www.zimmer.com

SOURCE Zimmer Holdings, Inc.

http://www.zimmer.com